Medicare Enrolled
Dr. Robert Menzies, M.D.
Sports Medicine (Family Medicine) Physician · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Menzies from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menzies?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Menzies
Dr. Robert Menzies is a sports medicine physician in Fort Worth, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Menzies performed 2,500 Medicare services across 1,045 unique beneficiaries.
Between the years covered by Open Payments, Dr. Menzies received a total of $73,907 from 71 pharmaceutical and/or device companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine (family medicine) physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Menzies is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 23% volume in TX
$73,907 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,500
Medicare services
Top 23% in TX for sports medicine (family medicine) physician
1,045
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,113 | $64 | $358 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
201 | $71 | $950 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 132 | $35 | $399 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
127 | $76 | $531 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
123 | $44 | $319 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
109 | $71 | $838 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
108 | $77 | $1,100 |
| Destruction of peripheral nerve or branch | 90 | $114 | $679 |
| Laser vein destruction with imaging guidance This procedure uses laser energy to destroy a faulty vein in the arm or leg. Imaging guidance is used to ensure accurate placement during the treatment. |
75 | $764 | $8,800 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
70 | $31 | $174 |
| Ultrasound-guided injection into multiple incompetent leg veins A procedure where a chemical agent is injected into several faulty veins in the same leg. Ultrasound guidance is used to ensure accurate placement of the injection. |
66 | $1,139 | $6,400 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
49 | $42 | $950 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
37 | $101 | $899 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
36 | $58 | $441 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
32 | $83 | $325 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
29 | $125 | $475 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
27 | $37 | $713 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
20 | $105 | $1,145 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
20 | $223 | $2,007 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
20 | $68 | $833 |
| Anesthetic or steroid injection into axillary nerve This procedure involves injecting a pain-relieving medication or steroid directly into the axillary nerve in the upper arm and shoulder area. |
16 | $128 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$73,907
Total received (2018-2024)
Avg $10,558/year across 7 years
Top 3% in TX for sports medicine (family medicine) physician
71
Companies
393
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$32,603 (44.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,207 (42.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,097 (13.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,036
2023
$11,082
2022
$10,379
2021
$14,331
2020
$10,319
2019
$10,283
2018
$3,476
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$62,751
Arthrex, Inc.
$1,515
Pylant Medical
$1,310
Pacira Pharmaceuticals Incorporated
$826
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$666
Medtronic Vascular, Inc.
$614
ABBVIE INC.
$420
Collegium Pharmaceutical, Inc.
$404
Amgen Inc.
$375
SI-BONE, Inc.
$301
SI-BONE, INC.
$285
Flowonix Medical Incorporated
$252
Tactile Systems Technology Inc
$224
AbbVie Inc.
$210
Medtronic, Inc.
$197
Scilex Pharmaceuticals Inc.
$195
Zyla Life Sciences
$182
Boston Scientific Corporation
$176
Avanos Medical
$162
Merz Pharmaceuticals, LLC
$144
PFIZER INC.
$137
MML US, Inc.
$129
Horizon Therapeutics plc
$117
GRT US Holding, Inc.
$117
BOSTON SCIENTIFIC CORPORATION
$111
Daiichi Sankyo Inc.
$106
Biohaven Pharmaceuticals, Inc.
$103
HydroCision, Inc.
$103
Pernix Therapeutics Holdings, Inc.
$100
Almatica Pharma LLC
$99
ARBOR PHARMACEUTICALS, INC.
$97
Flexion Therapeutics, Inc.
$91
Virtus Pharmaceuticals LLC
$85
Lundbeck LLC
$80
Purdue Pharma L.P.
$75
Novartis Pharmaceuticals Corporation
$75
Zyla Life Sciences, Inc.
$74
Allergan, Inc.
$61
BioDelivery Sciences International, Inc.
$60
Lilly USA, LLC
$58
Shield Therapeutics Inc
$53
Radius Health, Inc.
$50
ASSERTIO THERAPEUTICS, Inc.
$47
Arbor Pharmaceuticals, Inc.
$43
Medtronic USA, Inc.
$42
Abbott Laboratories
$41
Vision Quest Industries Inc.
$38
Assertio Therapeutics, Inc.
$38
Biocompatibles, Inc.
$33
BIOTRONIK NRO, Inc.
$32
Biohaven Pharmaceutical Holding Company Ltd.
$31
PAINTEQ LLC
$31
VERTEX PHARMACEUTICALS INCORPORATED
$31
Nevro Corp.
$28
Kaleo, Inc.
$27
Egalet US Inc
$26
Shionogi Inc
$26
USWM, LLC
$18
US WorldMeds, LLC
$18
SCILEX PHARMACEUTICALS INC.
$18
Azurity Pharmaceuticals, Inc.
$17
Aesculap, Inc.
$17
DJO, LLC
$17
Eisai Inc.
$17
Kowa Pharmaceuticals America, Inc.
$16
Forte Bio-Pharma LLC
$16
DePuy Synthes Sales Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
Allergan Inc.
$12
AstraZeneca Pharmaceuticals LP
$11
Stratus Medical, LLC
$1
Top 3 companies account for 88.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAPTIVESTIM · AIMOVIG · AJOVY · ARYMO ER · ASCENDA · Aesculap · Aimovig · BELBUCA · BIOTRONIK · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · COOLIEF COOLED RADIOFREQUENCY · COOLIEF* COOLED RADIOFREQUENCY · Cambia · ClosureFast · DUEXIS · Dayvigo · EMGALITY · EVLT · Evzio · Exparel · FLECTOR · FLEXITOUCH · Flexitouch Plus · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · Gralise · HORIZANT · HYSINGLA ER · Horizant · IFUSE IMPLANT · INTELLIS ADAPTIVESTIM · Iovera · LEVORPHANOL TARTRATE · LYRICA · Lucemyra · Lucemyra/Lofexidine · MAGNIFUSE · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NEEDLES - ALL · NURTEC ODT · Nimbus · Omnia · PAINTEQ · PENNSAID · PROCLAIM · Proclaim Family of SCS IPGs · Prometra II · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · ReActiv8 · SPECTRA WAVEWRITER · SPRIX · SYMPROIC · SYNCHROMEDII · Seglentis · Senza Spinal Cord Stimulation System · Symproic · TenJet · Tymlos · UBRELVY · VARITHENA · VENACURE 1470 PRO · VYEPTI · Varithena Administration Pack · VenaCure 1470 Pro · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xeomin · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 3% for sports medicine (family medicine) physician in TX.
Equivalent to $2,956 per 100 Medicare services performed
Geographic Context
Sports medicine physicians within 10 mi
21
Per 100K population
1.0
County median income
$81,905
Nearest hospital
MESA SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Menzies is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), with mixed engagement industry engagement in the top 3% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Menzies experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Menzies performed 1,113 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Menzies receive payments from pharmaceutical companies?
Yes. Dr. Menzies received a total of $73,907 from 71 companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menzies's costs compare to other sports medicine physicians in Fort Worth?
Dr. Menzies's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menzies) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Sports Medicine Physicians in Fort Worth
Browse sports medicine physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Sports Medicine Physicians in TX
Sports medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Sports Medicine Physicians in TX
Which TX sports medicine physicians receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc.
By company
Arthrex, Inc. Payments to Doctors
See all physicians who received payments from Arthrex, Inc.
By company
Pylant Medical Payments to Doctors
See all physicians who received payments from Pylant Medical.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology